Atlas Trials

Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects

Clinical trial NCT01359605 · COMPLETED

Trial details

NCT number
NCT01359605
Sponsor
Anthera Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2011-06-01
Primary completion
2011-07-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.